Neurofibromatosis type 1 complications in the pediatric age: a hundred cases follow-up;Complications de la neurofibromatose de type 1 chez l'enfant : à propos d'une série de 100 cas

Archives de Pediatrie

Volumn 13, Issue 7, 2006, Pages 1009-1014

  Bonnemaison, E ^a   Roze Abert, B ^a   Lorette, G ^b,d   Sirinelli, D ^a,d   Boscq, M ^a,d   Mazjoub, S ^c,d   De Courtivron, B ^a,d   Bonnard, C ^a,d   Despert, F ^a,d   Toutain, A ^c,d   Maheut Lourmiere J ^a,d   Barthez, M A ^a,d   Castelnau, P ^a,d,e  

^a Centre de Pediatrie Clocheville   (France)

^b SERVICE DE DERMATOLOGIE   (France)

^c CHU BRETONNEAU   (France)

^d UNIVERSITY HOSPITAL OF TOURS   (France)

^e INSERM   (France)

Author keywords

Child; Follow up; Neurofibromatosis 1

Indexed keywords

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CAFE AU LAIT SPOT; CHILD; CLINICAL FEATURE; EARLY DIAGNOSIS; FAMILY HISTORY; FEMALE; FOLLOW UP; GENETIC DISORDER; HUMAN; LEARNING DISORDER; MAJOR CLINICAL STUDY; MALE; NEUROFIBROMATOSIS; OPTIC NERVE GLIOMA; PATIENT CARE; SAMPLE SIZE; SEX RATIO; INFANT; NEWBORN; PRESCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; LEARNING DISORDERS; MALE; NEUROFIBROMATOSIS 1;

EID: 33745473702     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2006.03.149     Document Type: Article

References (26)

1. Huson S.M. The neurofibromatosis: a pathogenetic and clinical overview (1994), Chapmann & Hall, London
2. Neurofibromatosis N.I.H. Consensus Development Institutes of Health. Conference Statement National. Arch. Neurol. 45 (1988) 575-578
3. Barker D., Wright E., Nguyen K., et al. Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17. Science 236 (1987) 1100-1102
4. Marchuk D.A., Saulino A.M., Tavakkol R., et al. cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics 11 (1991) 931-940
5. Gutmann D.H., Wood D.L., and Collins F.S. Identification of the neurofibromatosis type 1 gene product. Proc. Natl. Acad. Sci. USA 88 (1991) 9658-9662
6. Friedman J.M., and Birch P.H. Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1728 patients. Am. J. Med. Genet. 70 (1997) 138-143
7. Zoller M.E., Rembeck B., Akesson H.O., et al. Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Goteborg, Sweden. Acta Derm. Venereol. 75 (1995) 136-140
8. Pinson S., Creange A., Barbarot S., et al. Neurofibromatose 1: recommandations de prise en charge. Arch. Pediatr. 9 (2002) 49-60
9. Landrieu P. Comment surveiller un enfant atteint de neurofibromatose de type 1 ?. Arch. Pediatr. 9 (2002) 771-773
10. Cnossen M.H., de Goede-Bolder A., van den Broek K.M., et al. A prospective 10 years follow up study of patients with neurofibromatosis type 1. Arch. Dis. Child. 78 (1998) 408-412
11. Lund A.M., and Skovby F. Optic gliomas in children with neurofibromatosis type 1. Eur. J. Pediatr. 150 (1991) 835-838
12. Lopez Pison J., Cuadrado-Martin M., Boldova-Aguar M.C., et al. Neurofibromatosis in children. Our experience. Rev. Neurol. 37 (2003) 820-825
13. Obringer A.C., Meadows A.T., and Zackai E.H. The diagnosis of neurofibromatosis-1 in the child under the age of 6 years. Am. J. Dis. Child. 143 (1989) 717-719
14. DeBella K., Szudek J., and Friedman J.M. Use of the national institutes of health criteria for diagnosis of neurofibromatosis-1 in children. Pediatrics 105 (2000) 608-614
15. Riccardi V.M. Neurofibromatosis; phenotype natural history and pathogenesis. 2nd ed (1992), The Johns Hopkins University Press, Baltimore
16. Hofman K.J., Harris E.L., Bryan R.N., et al. Neurofibromatosis type 1: the cognitive phenotype. J. Pediatr. 124 (1994) S1-S8
17. Nguyen The Tich S., Mahé J.-Y., Coutant X., et al. Revue: Neurofibromatose. Trouble de l'apprentissage : dépistage et prise en charge. Med. Ther. 3 (1997) 636-639
18. Fermer R.E., Hughes R.A., and Weinman J. Intellectual impairment in neurofibromatosis 1. J. Neurol. Sci. 138 (1996) 125-133
19. North K.N., Riccardi V., Samango-Sprouse C., et al. Cognitive function and academic performance in neurofibromatosis 1: consensus statement from the NF1 Cognitive Disorders Task Force. Neurology 48 (1997) 1121-1127
20. Vivarelli R., Grosso S., Calabrese F., et al. Epilepsy in neurofibromatosis 1. J. Child Neurol. 18 (2003) 338-342
21. Matsui I., Tanimura M., Kobayashi N., et al. Neurofibromatosis type 1 and childhood cancer. Cancer 72 (1993) 2746-2754
22. Narod S.A., Stiller C., and Lenoir G.M. An estimate of the heritable fraction of childhood cancer. Br. J. Cancer 63 (1991) 993-999
23. Listernick R., Louis D.N., Packer R.J., et al. Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann. Neurol. 41 (1997) 143-149
24. Lund A.M., and Skovby F. Optic gliomas in children with neurofibromatosis type 1. Eur. J. Pediatr. 150 (1991) 835-838
25. North K., Joy P., Yuille D., et al. Specific learning disability in children with neurofibromatosis type 1: significance of MRI abnormalities. Neurology 44 (1994) 878-883
26. Moore B.D., Slopis J.M., Schomer D., et al. Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis. Neurology 46 (1996) 1660-1668